Follica

edit

Follica, Inc. is developing novel therapies for conditions and disorders of the hair follicle, the epicenter for the development and replenishment of human hair and skin. Treatments for conditions of the follicle account for a total market exceeding $10 billion annually, despite a lack of truly effective solutions.

Milestones

edit

• Received $11M in Series B funding. (8/12/08)
  Posted 6/23/09 at 5:56am
• William Ju, President, CEO & Member, Board of Directors added.
  Posted 6/23/09 at 5:47am
• G. Kirk Raab, Chairman, Board of Directors added.
  Posted 6/23/09 at 5:47am

Videos

Screenshots

edit

Above: Follica Screenshot -- #1
Uploaded: 6/23/09

Sources

1. Follica Announces $11M in New Financing and Expanded Team (follicabio.com) [edit]